JRM Investment Counsel’s Avantis Emerging Markets Equity ETF AVEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.6M Buy
337,757
+1,056
+0.3% +$97.4K 7.89% 5
2026
Q1
$27.1M Buy
336,701
+19,940
+6% +$1.66M 7.23% 5
2025
Q4
$24.4M Buy
316,761
+4,925
+2% +$377K 7.06% 5
2025
Q3
$23.4M Buy
311,836
+12,572
+4% +$898K 7.01% 5
2025
Q2
$20.5M Buy
299,264
+44,788
+18% +$2.82M 6.59% 5
2025
Q1
$15.3M Sell
254,476
-16,020
-6% -$963K 5.22% 7
2024
Q4
$15.9M Buy
270,496
+16,223
+6% +$1.01M 5.62% 6
2024
Q3
$16.4M Sell
254,273
-6,672
-3% -$408K 5.66% 5
2024
Q2
$15.9M Buy
260,945
+6,527
+3% +$391K 5.38% 6
2024
Q1
$14.7M Buy
254,418
+74,655
+42% +$4.2M 4.87% 7
2023
Q4
$10.1M Buy
179,763
+66,796
+59% +$3.59M 3.7% 11
2023
Q3
$5.96M Buy
112,967
+2,969
+3% +$161K 2.64% 12
2023
Q2
$5.92M Buy
109,998
+70,753
+180% +$3.76M 2.51% 12
2023
Q1
$2.08M Buy
+39,245
New +$2.08M 0.91% 17

Other funds holding AVEM

JRM Investment Counsel's AVEM Position: Q2 2026 in Review

JRM Investment Counsel increased its Avantis Emerging Markets Equity ETF (AVEM) stake by 0.31% in Q2 2026, buying an estimated $97.4K and bringing the position to 337,757 shares worth $32.6M. The position accounts for 7.89% of the portfolio, ranked #5.

JRM Investment Counsel first reported a position in AVEM in Q1 2023 and has held it in 14 quarters since. 973 funds tracked by Wall St. Rank hold AVEM as of Q2 2026.

  • JRM Investment Counsel held 337,757 shares of Avantis Emerging Markets Equity ETF worth $32.6M as of Q2 2026.
  • JRM Investment Counsel bought 1,056 Avantis Emerging Markets Equity ETF shares in Q2 2026, an estimated $97.4K.
  • Avantis Emerging Markets Equity ETF made up 7.89% of JRM Investment Counsel's portfolio in Q2 2026, its #5 holding.
  • JRM Investment Counsel first reported a position in Avantis Emerging Markets Equity ETF in Q1 2023 and has held it in 14 quarters since.
  • 973 funds tracked by Wall St. Rank held Avantis Emerging Markets Equity ETF as of Q2 2026.

Based on JRM Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.